Synonym
Arofylline; Arofyllin; LAS 31025
IUPAC/Chemical Name
3-(p-Chlorophenyl)-1-propylxanthine
InChi Key
GVTLDPJNRVMCAL-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H13ClN4O2/c1-2-7-18-13(20)11-12(17-8-16-11)19(14(18)21)10-5-3-9(15)4-6-10/h3-6,8H,2,7H2,1H3,(H,16,17)
SMILES Code
O=C(N1CCC)N(C2=CC=C(Cl)C=C2)C3=C(NC=N3)C1=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
304.73
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Chorostowska-Wynimko J, Kus J, Skopińska-Rózewska E. Theophylline inhibits free oxygen radicals production by human monocytes via phosphodiesterase inhibition. J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 1):95-103. PubMed PMID: 18204120.
2: Guidos Fogelbach GA, Rodríguez Velasco JG, Almeida Arvizu VM. [Current and future approaches for the treatment of inflammatory diseases of inferior respiratory tract]. Rev Alerg Mex. 2006 May-Jun;53(3):94-100. Review. Spanish. PubMed PMID: 16970111.
3: Ferrer L, Alberola J, Queralt M, Brazís P, Rabanal R, Llenas J, Puigdemont A. Clinical anti-inflammatory efficacy of arofylline, a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis. Vet Rec. 1999 Aug 14;145(7):191-4. PubMed PMID: 10501583.
4: Newman SP, Rivero X, Luria X, Hooper G, Pitcairn GR. A scintigraphic study to evaluate the deposition patterns of a novel anti-asthma drug inhaled from the Cyclohaler dry powder inhaler. Adv Drug Deliv Rev. 1997 Jun 9;26(1):59-67. PubMed PMID: 10837533.
5: Olivry T, Mueller RS; International Task Force on Canine Atopic Dermatitis. Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Vet Dermatol. 2003 Jun;14(3):121-46. Review. PubMed PMID: 12791047.
